1-Isopropylpiperazine → 5-(4-Chlorophenyl)-2-(4-isopropylpiperazin-1-yl)-pyrimidine dihydrochloride
반응식
[Cl:1][C:2]1[N:7]=[CH:6][C:5]([C:8]2[CH:13]=[CH:12][C:11]([Cl:14])=[CH:10][CH:9]=2)=[CH:4][N:3]=1.[CH:15]([N:18]1[CH2:23][CH2:22][NH:21][CH2:20][CH2:19]1)([CH3:17])[CH3:16]>>[ClH:1].[ClH:1].[Cl:14][C:11]1[CH:12]=[CH:13][C:8]([C:5]2[CH:4]=[N:3][C:2]([N:21]3[CH2:22][CH2:23][N:18]([CH:15]([CH3:17])[CH3:16])[CH2:19][CH2:20]3)=[N:7][CH:6]=2)=[CH:9][CH:10]=1참가 물질
3
실험 절차
The title compound was prepared by a similar procedure to that described in Example 1, starting from 2-chloro-5-(4-chlorophenyl)pyrimidine and 1-isopropylpiperazine.
출처 및 근거
- ORD 기록
- ord-08228562b58844739bbd92c90aefbfdf
- 출처 데이터셋
- uspto-grants-2013_08
- 특허 번호
- US08501739B2
반응 노트
불러오는 중…